BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

News: BNO Bionomics Announces The Completion Of Enrollment In Phase 2b ATTUNE Clinical Trial Of...

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    27/04/23
    20:10
    Post #: 67489183

    April 27 (Reuters) - Bionomics Ltd (BNO) :

    • BIONOMICS ANNOUNCES THE COMPLETION OF ENROLLMENT IN PHASE 2B ATTUNE CLINICAL TRIAL OF BNC210 IN PATIENTS WITH POST-TRAUMATIC STRESS DISORDER (PTSD)
    • BIONOMICS ANNOUNCES THE COMPLETION OF ENROLLMENT IN PHASE 2B ATTUNE CLINICAL TRIAL OF BNC210 IN PATIENTS WITH POST-TRAUMATIC STRESS DISORDER (PTSD)
    • BIONOMICS LTD - TOPLINE RESULTS ARE EXPECTED IN Q3 OF 2023
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Listen: HotCopper Wire Podcast 023 – Glowing gold, shining silver, and... wheat collusion?
right-arrow Created with Sketch.
NEWS Arrowsmith North Silica Sand Project granted works approval
right-arrow Created with Sketch.
NEWS HotCopper Highlights: 4DS Memory's strategic review flags strategic review & more
right-arrow Created with Sketch.
NEWS Rubix advances proposed acquisition of prospective Bauxite Projects in Africa
right-arrow Created with Sketch.
NEWS Vulcan signs first major Phase One contract with NESI
right-arrow Created with Sketch.
NEWS Marquee confirms high-grade antimony ahead of maiden JORC resource
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.